Feeding tube

Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition

Retrieved on: 
Friday, April 5, 2024
Choline, Plasma, Liver, Nutritional science, Route of administration, Liver disease, Steatosis, Short bowel syndrome, Metabolism, Patient, Choline chloride, Cancer, ESPEN, Parenteral nutrition, Adolescence, Liver injury, Hepatology, Tubing (recreation), Fibrosis, Guideline, Society, Therapy, Copenhagen University Hospital, Safety, Pharmacokinetics, PN, FDA, ASPEN, Rigshospitalet, Food, Feeding tube, Extractive metallurgy

IV Choline Chloride has the potential to become the first FDA-approved IV formulation of choline for the 40,000 PN patients in the U.S.

Key Points: 
  • IV Choline Chloride has the potential to become the first FDA-approved IV formulation of choline for the 40,000 PN patients in the U.S.
  • The Company plans to advance the development of IV Choline Chloride as a source of choline for adult and adolescent patients on long-term PN.
  • The FDA has granted IV Choline Chloride Orphan Drug Designation for the prevention of choline deficiency in PN patients.
  • “We look forward to advancing the clinical development of IV Choline Chloride, which we believe has the potential to become the first FDA approved IV choline therapy for patients dependent on PN.

Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference

Retrieved on: 
Friday, February 23, 2024
Science, Other Science, Biotechnology, Research, Pharmaceutical, Managed Care, Health, Fitness & Nutrition, Ironwood Pharmaceuticals, SBS, Ileostomy, Nutrition, Safety, University, PS, Quality of life, Infection, Drug development, Jejunostomy, Hope, Short bowel syndrome, Risk, Conference, Faculty, Society, Nutrient, Pharmacokinetics, Route of administration, Abstract, ASPEN, Feeding tube, Medication, STARS, Pharmaceutical industry

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced today that the company will present findings from four studies evaluating apraglutide in adults with short bowel syndrome with intestinal failure (SBS-IF), a condition in which they are dependent on parenteral support, during the American Society for Parenteral and Enteral Nutrition (ASPEN) 2024 Nutrition Science & Practice Conference.

Key Points: 
  • Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced today that the company will present findings from four studies evaluating apraglutide in adults with short bowel syndrome with intestinal failure (SBS-IF), a condition in which they are dependent on parenteral support, during the American Society for Parenteral and Enteral Nutrition (ASPEN) 2024 Nutrition Science & Practice Conference.
  • ASPEN is being held from March 2-5, 2024, in Tampa, Florida.
  • SBS is a serious and chronic condition where there is diminished absorptive capacity for fluids and/or nutrients, typically resulting from extensive intestinal resection.
  • “These findings continue to deepen our understanding of GLP-2 and the potential of apraglutide to help adult patients with SBS who are dependent on PS, including those with colon-in-continuity.

Enteral Feeding Tubes Global Strategic Business Report - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 5, 2023
Medical Devices, Health, Shift, Clinical nutrition, Virus, Real, Incidence, Treatment, Hospital, Feeding tube, Geography, Central Statistics Office (India), Business case, Vaccine, Health care, Agriculture, Dairy, Enteral administration, Malnutrition

As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?

Key Points: 
  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    Hospitals & Long-term Care Facilities: The Major Users of Enteral Feed Tubes
    Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    World Diabetes and Population Statistics (2021, 2030 & 2045)
    Global Diabetes Mellitus Population (in Million) by Geographic Region: 2021, 2030 and 2045
    Unrelenting Threat of HIV/AIDS Infection: An Opportunity for Enteral Feeding Tubes Market
    Enteral Nutrition Emerges as a Key Therapy for Preterm Infants, Fueling Growth in Enteral Feeding Tubes Market
    Countries with Highest Preterm Birth Rates: Number of Preterm Births Per 100 Live Births by Top Countries
    Shift towards Home Healthcare Presents Opportunities for Medical Nutrition, Driving Growth in Enteral Feeding Tubes Market: Global Home Healthcare Market (in US$ Billion) for the Years 2020, 2022, 2024 and 2026
    Role of Enteral Nutrition Therapy in the Treatment of Malnutrition: A Business Case for Enteral Feeding Tubes Market
    Gastrostomy Tube Feeding Devices Market: Poised for Healthy Growth
    Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023

Global Parenteral Nutrition Market to Reach $11.8 Billion by 2030

Retrieved on: 
Tuesday, March 14, 2023
Pressure, Reference, Element, Investment, Parenteral nutrition, Food, Vitamins & Minerals, COVID, Climate change, Enteral administration, Home care, Feeding tube, Growth, Hospital, COVID-19, Risk, Production, End-use certificate, Route of administration, PN, Pharmaceutical industry, Pet industry, Floral industry, Rare-earth element, Cochineal, Dietary supplement, Beauty salon, Sulfur, Retail, Gum arabic, Birth control, Infant

In the changed post COVID-19 business landscape, the global market for Parenteral Nutrition estimated at US$6.5 Billion in the year 2022, is projected to reach a revised size of US$11.8 Billion by 2030, growing at aCAGR of 7.7% over the period 2022-2030.

Key Points: 
  • In the changed post COVID-19 business landscape, the global market for Parenteral Nutrition estimated at US$6.5 Billion in the year 2022, is projected to reach a revised size of US$11.8 Billion by 2030, growing at aCAGR of 7.7% over the period 2022-2030.
  • Single Dose Amino Acid Solution, one of the segments analyzed in the report, is projected to record 8.2% CAGR and reach US$4.1 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $1.8 Billion, While China is Forecast to Grow at 12.9% CAGR
    The Parenteral Nutrition market in the U.S. is estimated at US$1.8 Billion in the year 2022.
  • China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 12.9% over the analysis period 2022 to 2030.

United States Home Infusion Market Report 2022: A $20.6 Billion Market by 2027 - Leading Players are CVS, BD & Co, Smith & Nephew, Terumo, ICU Medical, Moog, and InfuSystems - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 10, 2023
Women, Other Health, Seniors, Pharmaceutical, Men, Telemedicine, Virtual Medicine, Oncology, Medical Devices, Infectious Diseases, Hospitals, Consumer, Managed Care, Medical Supplies, Cardiology, General Health, Biotechnology, COVID-19, Health, Feeding tube, Becton, Dickinson and Company headquarters, Injury, COVID-19, Coagulopathy, DME, Parenteral nutrition, CMS, Centers for Medicare & Medicaid Services, Quality of life, Safety, CVS Health, Smith & Nephew, Risk, Human services, Insight, Conditional sentence, Urinary tract infection, Skin, ICU Medical, Organization, Medicare, United States Department of Health and Human Services, Patient, Prevalence, Moog, US, Infection, USD, Physician, Medical device, Vaccine, Health insurance, Pharmaceutical industry, Health, Indication, Growth, Antibody

United States Home Infusion Market will reach US$ 20.6 Billion by 2027.

Key Points: 
  • United States Home Infusion Market will reach US$ 20.6 Billion by 2027.
  • Therefore, as home infusion therapy aids in managing chronic conditions of the elderly populace, the market will witness significant growth in the future.
  • In addition, the acceptance of new technologies in the home infusion therapy market will support the industry's growth.
  • CVS Health, Becton, Dickinson and Company, Smith & Nephew plc, Terumo Corporation, ICU Medical, Moog, and InfuSystems Holdings are the leading competitors in the U.S. home infusion therapy market.

Global Home Infusion Therapy Market Report (2022-2027): Ongoing Enhancements and Technological Advancements in Home Infusion Therapy Present Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, November 25, 2022
Health, Pharmaceutical, Growth, Ansoff Matrix, Health minister, Joint Medical Service (Germany), Pump, Risk, Feeding tube, USD, Eli Lilly and Company, Geography, Infection, Interim, Nutritional science, SWOT, Becton, Dickinson and Company headquarters, Needleless connector, Market development, Baxter International, Investment, Medical device, Pharmaceutical industry

By Indication, the market is classified into Anti-Infective, Chemotherapy, Enteral Nutrition, Hydration Therapy, Imunoglobulin Therapy, Total Parenteral Nutrition, and Others.

Key Points: 
  • By Indication, the market is classified into Anti-Infective, Chemotherapy, Enteral Nutrition, Hydration Therapy, Imunoglobulin Therapy, Total Parenteral Nutrition, and Others.
  • The report presents a detailed Ansoff matrix analysis for the Global Home Infusion Therapy Market.
  • The analyst analyses the Global Home Infusion Therapy Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Global Enteral Feeding Formulas Market Report 2022: Ease of Use and Low Costs Driving Adoption - ResearchAndMarkets.com

Retrieved on: 
Monday, November 7, 2022
Managed Care, Diabetes, Health, General Health, Pharmaceutical, Food, Beverage, Oncology, Neurology, Retail, Hospitals, Fitness & Nutrition, Administration, Gastrointestinal tract, Parenteral nutrition, Intensive care unit, Growth, Nutrient, Society, Feeding tube, CAGR, American Society for Parenteral and Enteral Nutrition, Oncology, Route of administration, ASPEN, Stroke, Rehabilitation, Food, Nursing, GI, Degenerative disease, Malnutrition, Patient, Cancer, Abbott Laboratories, Hospital, Medicine, Milk, Diabetes

The Global Enteral Feeding Formulas Market size is expected to reach $8.6 billion by 2028, rising at a market growth of 8.5% CAGR during the forecast period.

Key Points: 
  • The Global Enteral Feeding Formulas Market size is expected to reach $8.6 billion by 2028, rising at a market growth of 8.5% CAGR during the forecast period.
  • This market is also expanding as many nursing homes and home healthcare organizations prefer enteral feeding formulas for rehabilitation of post-surgery patients.
  • as more neonatal care units develop, the market for enteral feeding formulas market will experience further growth.
  • These misunderstandings of the proper use of enteral feeding is expected to negatively impact the growth of the enteral feeding formula market.

Enteral Nutrition Market Research Report 2022: Growing at a CAGR of 9.62% to $8.6+ Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, June 24, 2022
Biotechnology, Online Retail, Diabetes, Health, General Health, Specialty, Pharmaceutical, Oncology, Retail, Hospitals, Fitness & Nutrition, Online, Feeding tube, Acquisition, Decision-making, Neurology, USD, Strategic management, Market share analysis, Value, Mergers and acquisitions, Business Growth Fund, Critical care, Customer support, Growth, Application, Research report, Market share, Collaborative partnership, Investment, Nutrition, CAGR, Diabetes, Weakness, Use, Journal of Parenteral and Enteral Nutrition, News, Compound annual growth rate, Gaps, Retail, Retail, Oncology

This research report categorizes the Enteral Nutrition to forecast the revenues and analyze the trends in each of the following sub-markets:

Key Points: 
  • This research report categorizes the Enteral Nutrition to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Product, the market was studied across Nutrition for Chronic Illness and Standard Formula.
  • Based on Distribution Channel, the market was studied across Hospital Sale, Online, and Retail.
  • This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Enteral Nutrition market considering the current update on the conflict and its global response.
  • The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market.

Global Home Infusion Therapy Market Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 26, 2022
Health, Pharmaceutical, Population, Conditional sentence, Pump, Joint, Parenteral nutrition, Patient, Subclinical infection, US, IV, Industry, Insight, Feeding tube, Awareness, Nutrient, Specialty, Syringe, Eyeish, Technology, Ageing, Adoption, CAGR, Prevalence, Pharmaceutical industry, Medical device, COVID-19, Growth

Global Home Infusion Therapy Market is expected to reach US$ 45.46 billion in 2027 from $27.97 billion in 2021, growing at a CAGR of 8.43%.

Key Points: 
  • Global Home Infusion Therapy Market is expected to reach US$ 45.46 billion in 2027 from $27.97 billion in 2021, growing at a CAGR of 8.43%.
  • Patients have shifted from conventional treatments to specialty infusion therapy treatments such as home infusion therapy over the years.
  • The demand for home infusion therapy devices will increase in the coming years as the application spectrum of infusion devices expands, along with the growing demand for infusion devices in the home care market.
  • By product, the home infusion therapy market is divided into four categories: infusion pumps, intravenous sets, IV cannulas, and needleless connectors.

Medscape Education to Host Nine Gastroenterology Symposia at Digestive Disease Week

Retrieved on: 
Thursday, May 19, 2022
Congress, American Society for Gastrointestinal Endoscopy, Medscape, Physician, Education, American Gastroenterological Association, Clostridioides difficile (bacteria), Irritable bowel syndrome, ASPEN, Rome, American College, Helicobacter pylori, American Association for the Study of Liver Diseases, DDW, Ulcerative colitis, AASLD, AGA, Crohn's & Colitis Foundation, Multimedia, Infection, International Foundation, View, Crohn's disease, Nursing, Route of administration, Institute of Liver and Biliary Sciences, CE, Society, CME, Association, Cleveland Clinic, American Society for Parenteral and Enteral Nutrition, Rehabilitation, Weill Cornell Medical College in Qatar, Gastroenterology, Feeding tube, American College of Gastroenterology, ACG, ASGE, Group, American Association, Degenerative disease, ROME, Gastrointestinal Endoscopy, Medicine, Online shopping

NEW YORK, May 19, 2022 /PRNewswire/ -- Medscape Education will host nine educational symposia at Digestive Disease Week (DDW) 2022 in San Diego May 21- 24, estimated to reach 3,000 gastroenterology specialists attending the conference in person.

Key Points: 
  • NEW YORK, May 19, 2022 /PRNewswire/ -- Medscape Education will host nine educational symposia at Digestive Disease Week (DDW) 2022 in San Diego May 21- 24, estimated to reach 3,000 gastroenterology specialists attending the conference in person.
  • The live symposia will address key topics in gastroenterology including inflammatory conditions and infectious diseases, such as ulcerative colitis, Helicobacter pylori infection, hepatobiliary carcinoma, Crohn's disease, Clostridioides difficile, irritable bowel syndrome, and more.
  • More than 30 expert clinicians from diverse education and practice environments, including Cleveland Clinic and Weill Cornell Medical will participate as presenting faculty.
  • Medscape's staff of gastroenterology experts, working with world-renowned faculty, are poised to engage clinicians through interesting, relevant, and interactive sessions," said Douglas Kaufman, Group Vice President of Medscape Education.